Proton pump inhibitors and 180-day mortality in the elderly after Clostridium difficile treatment

Proton pump inhibitors and 180-day mortality in the elderly after Clostridium difficile treatment

Abstract Background There is a reported association between proton pump inhibitor (PPI) exposure and increased risk of Clostridium difficile infection (CDI), but less is known about how this class of medications taken during treatment might influence mortality after CDI. Here we examine 180-day mort...

Full description

Bibliographic Details
Main Authors: Evan Stuart Bradley, Emily Howe, Xun Wu, John P. Haran
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Gut Pathogens
Subjects:
Clostridium difficile
Enteric pathogens
Infectious disease
Medication safety
Proton pump inhibitors
Online Access:http://link.springer.com/article/10.1186/s13099-019-0309-6

Internet

http://link.springer.com/article/10.1186/s13099-019-0309-6

Similar Items